PedAM
Pediatric Disease Annotations & Medicines
| Disease | hiv infections |
| Symptom | C0023787|lipodystrophy |
| Sentences | 11 |
| PubMedID- 24088799 | Special stress will be given to the most prevalent lipodystrophy that associated with hiv infection - describing the similarities with congenital lipodystrophies and its pathogenic mechanisms. |
| PubMedID- 21919542 | Conclusion: haart including nevirapine has a limited impact on components of lipodystrophy in patients with hiv infection. |
| PubMedID- 24625638 | Studies indicate that the prevalence of lipodystrophy in patients with hiv infection on art ranges from 11% to 83%.14 nevertheless, these findings are derived from different definitions of lipodystrophy, as well as distinct selection criteria and follow-up of the study population. |
| PubMedID- 22298602 | Objective: to evaluate the efficacy and safety of tesamorelin, a growth hormone releasing factor analogue approved by the food and drug administration in november 2010 for the treatment of lipodystrophy associated with hiv infection. |
| PubMedID- 26015783 | Have made a significantcontribution to the progress of knowledge about lipodystrophy pathogenesis in patients with hiv infection, which is still not clearly defined 9. |
| PubMedID- PMC3315926 | Seven hiv infected patients, normolipidemic with no lipodystrophy (group a) and seven hyperlipidemic with lipodystrophy (group b) were studied. |
| PubMedID- 21999362 | Pharmacogenetics of the lipodystrophy syndrome associated with hiv infection and combination antiretroviral therapy. |
| PubMedID- PMC3113081 | The purpose of this study was to estimate the levels of adiponectin and leptin in hiv infected patients with lipodystrophy and to correlate them to metabolic parameters. |
| PubMedID- 25320591 | Hence we conducted this study to assess the prevalence of lipodystrophy in hiv infected children on haart and its associated risk factors. |
| PubMedID- 25563033 | Met-syn is also associated with lipodystrophy in hiv infected (hiv+) adults taking antiretroviral therapies. |
| PubMedID- 23409405 | Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in hiv infected patients. |
Page: 1